Chemicals

Amyris to Acquire Sweet Protein Developer Oobli

Kavya SridharNovember 16, 20265 min read0 views

At a glance

  • The biomanufacturing company aims to combine its fermentation scale with Oobli's sugar-reduction ingredients.
  • Amyris announced that it will acquire Oobli, a developer of fermentation-derived sweet proteins, with the transaction expected to close in the coming weeks. The companies position the combination as a way to scale sweet proteins across food, beverage and other markets while honoring existing customer and brand partnerships.
Stainless-steel fermentation tanks, lab glassware and stylized protein structures illustrate the link between biomanufacturing scale and sweet-protein development.

Amyris, Inc. has announced that it will acquire Oobli Inc., a Davis, California-based developer of fermentation-derived sweet proteins used by food and beverage makers to cut sugar while retaining sweetness. Amyris, based in Emeryville, California, describes itself as a vertically integrated biomanufacturing company. The transaction is expected to close in the coming weeks.

The acquisition would combine Amyris' scientific and manufacturing capabilities with Oobli's expertise in protein fermentation. Amyris said the move follows its expansion earlier this year of manufacturing capacity at its advanced fermentation facility in Barra Bonita, Brazil. The company framed the deal as a commercial and technology expansion intended to accelerate its presence in protein- and peptide-based solutions across end markets.

Complementary platforms

"In Oobli, we see a commercial and technology platform that is a great complement to our own," Amyris CEO Kathy Fortmann said in the announcement. She said Oobli is positioned to change how sweetness reaches the market and that Amyris aims to apply its commercial scale and resources to accelerate that effort. Fortmann also said combining Oobli's protein expertise with Amyris' strain engineering, manufacturing scale and commercial capabilities could broaden capabilities in food and beverage, personal care, flavor and fragrance, agriculture and other areas.

Oobli's commercial portfolio of sweet proteins is expected to be the first to benefit from the combined platform. The company has spent the past decade refining a fermentation process for producing sweet proteins that occur naturally in rare fruits and berries found near the equator. According to the announcement, these proteins are the first of their kind in the sugar-reduction category.

How sweet proteins work

Sweet proteins are described as hundreds to thousands of times sweeter than sugar. They bind directly to sweet taste receptors and are metabolized by the body as protein, delivering sweetness without gut disruption or blood sugar spikes, according to the announcement. Oobli's portfolio includes Oubli Fruit, Serendipity Berry and Katemfe Fruit sweet proteins, known scientifically as brazzein, monellin and thaumatin, respectively.

The ingredients have FDA GRAS status for use as an ingredient and are FEMA GRAS-affirmed for use as a natural flavor, according to the announcement. With rising consumer awareness of metabolic health and the benefits of reducing sugar, the announcement positions sweet proteins as a tool for brands across sports and nutrition, dairy, beverages, chocolate, bakery and confectionery.

Scale and market reach

Oobli CEO Ali Wing said the company has long believed there was a better way to deliver the sweet taste consumers want without trade-offs to health and the environment. She described the combination with Amyris as providing the scale and resources to pursue Oobli's ambition of making sweet proteins a global standard in sweetness solutions.

Fortmann said biomanufactured solutions succeed when they align with consumer demand and market needs, and she said Oobli's platform does that by offering brands a way to address sweet taste, sugar reduction and clean label at the same time. Amyris said it looks forward to welcoming the Oobli team and realizing synergies between the two platforms.

Amyris said Oobli's existing customer commitments and brand partnerships will continue to be honored without interruption as the sweet protein portfolio expands within Amyris.

Reported by Kavya Sridhar, Fine, Electronic Chemicals and Strategic Sourcing Editor.